The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological.
Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and antibodies to expedite the process of novel drug identification and validation, for example.
Chen talks about the origins, importance and possible applications of recombinant DNA technology in drug discovery – as well as the opportunities it creates for drug discovery research.
Listen now to hear Chen outline the ways different levels of this technology can help increase the speed of drug identification, validation as well as the potential of recombinant proteins and antibodies when they are used in drug discovery.
